Women are two times more likely than men to die after receiving a combination of cancer immunotherapy drugs called checkpoint inhibitors, but it's not clear if that difference is due to side effects or because the treatment isn't working, researchers say.
Early detection of ovarian cancer helps boost a woman's survival, and the U.S. Food and Drug Administration on Monday approved a new imaging drug that can help spot tumors during surgery.
Since 1971, when the U.S. government made defeating cancer a goal and put major funding behind it, death rates for many cancers have plummeted, but some are increasing, according to a new American Cancer Society report.
